Evidence map›Paper›PMID 40115475›Full record

ArticleCentral European journal of urology2024

Profiles of urinal exosomal miRNAs derived from bladder cancer.

Ērika Bitiņa-Barlote, Juris Plonis, Margarita Andrejeva, Egils Vjaters, Jānis Gardovskis, Zanda Daneberga, Edvīns Miklaševičs, Miki Nakazawa-Miklaševiča

Abstract read
In one paragraph

Article in Central European journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ērika Bitiņa-BarloteInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.
Juris PlonisInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.
Margarita AndrejevaCenter of Oncology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Egils VjatersInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.
Jānis GardovskisInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.
Zanda DanebergaInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.
Edvīns MiklaševičsDepartment of Biology and Microbiology, Rīga Stradiņš University, Latvia.
Miki Nakazawa-MiklaševičaInstitute of Oncology and Molecular Genetics, Rīga Stradiņš University, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Exosomes contain nucleic acids and proteins inside of them. These are suggested as cell-cell communication materials and it is considered that they can modulate the status of other cells. Material and methods: To understand the bladder cancer (BC) related exosomal microRNAs (miRNAs), we compared the 752 urine exosomal miRNAs in healthy control (n = 7), low grade (LG) BC (n = 6) and high grade (HG) BC (n = 6) by RT-qPCR. Results: The differential expressing (DE) urine exosomal miRNAs (2 > fold regulation) were 96 and 78 in LG and HG, respectively. Our exosomal miRNAs profiles cover many miRNAs which have been reported in BC patients' tissues and other biofluids. Most DE exosomal miRNAs were up-regulated in the profiles. Seven up-regulated exosomal miRNAs in the LG group (miR-28-5p, miR-16-5p, miR-28-3p, miR-24-3p, miR-25-3p, miR-19b-3p and miR10b-5p) and 3 miRNAs in the HG group (miR-150-5p, miR-28-5p and miR28-3p) were found as directly Conclusions: Profiles of urinal exosomal miRNAs derived from BC manifested potentially epigenetic regulation of the

Indexed as

biofluidsbiomarkerbladder cancerliquid biopsymiRNAsurine exosomes

Identifiers

PMID40115475
PMCPMC11921953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.